Role of e-cigarettes and pharmacotherapy during attempts to quit cigarette smoking: The PATH Study 2013-16.

ABSTRACT:

Background

More smokers report using e-cigarettes to help them quit than FDA-approved pharmacotherapy.

Objective

To assess the association of e-cigarettes with future abstinence from cigarette and tobacco use.

Design

Cohort study of US sample, with annual follow-up.

Participants

US adult (ages 18+) daily cigarette smokers identified at Wave 1 (W1; 2013-14) of the PATH Study, who reported a quit attempt before W2 and completed W3 (n = 2443).

Exposures

Use of e-cigarettes, pharmacotherapy (including nicotine replacement therapy), or no product for last quit attempt (LQA), and current daily e-cigarette use at W2.

Analysis

Propensity score matching (PSM) of groups using different methods to quit.

Outcome measures

12+ months abstinence at W3 fro

SUBMITTER: Pierce JP 

PROVIDER: S-EPMC7467279 | biostudies-literature | 2020

REPOSITORIES: biostudies-literature